Main menu button

News

Equity Research Immunovia: Making headway with new cancer screening test
26 Feb 2025
Equity Research Immunovia: Making headway with new cancer screening test
Equity Research Immunovia
Equity research Teneo AI, Q4 2024: Teneo continues to deliver above expectations
25 Feb 2025
Equity research Teneo AI, Q4 2024: Teneo continues to deliver above expectations
Equity Research Teneo AI
Equity Research ALM Equity, Q4 2024: The market situation is about to improve
24 Feb 2025
Equity Research ALM Equity, Q4 2024: The market situation is about to improve
Equity Research ALM Equity
Equity research Viva Wine Group, Q4 2024: Positive growth momentum should continue
20 Feb 2025
Equity research Viva Wine Group, Q4 2024: Positive growth momentum should continue
Equity Research Viva Wine Group
Equity Research GIAB: Healthy core business risks reconstruction
20 Feb 2025
Equity Research GIAB: Healthy core business risks reconstruction
Equity Research
Equity research Nosa Plugs Q4, 2024: Strong growth and announced M&A strategy
20 Feb 2025
Equity research Nosa Plugs Q4, 2024: Strong growth and announced M&A strategy
Equity Research Nosa Plugs
Equity Research ALM Equity, Q4 2024: Stronger finances and an improved market
20 Feb 2025
Equity Research ALM Equity, Q4 2024: Stronger finances and an improved market
Equity Research ALM Equity
Equity research Viva Wine Group, Q4 2024: First impression
20 Feb 2025
Equity research Viva Wine Group, Q4 2024: First impression
Equity Research Viva Wine Group
Equity Research Ecoclime Q4 2024: Improvement expected in 2025
17 Feb 2025
Equity Research Ecoclime Q4 2024: Improvement expected in 2025
Equity Research
Equity Research KlaraBo, Q4 2024: Higher rent increases property value
17 Feb 2025
Equity Research KlaraBo, Q4 2024: Higher rent increases property value
Equity Research KlaraBo
Equity research CDON AB, Q4 2024: A mixed bag and room for improvement
16 Feb 2025
Equity research CDON AB, Q4 2024: A mixed bag and room for improvement
Equity Research CDON
Equity research Zinzino: Significant expansion of US business
14 Feb 2025
Equity research Zinzino: Significant expansion of US business
Equity Research Zinzino
Equity Research Ecoclime, Q4 2024: Weak quarter, but expected to improve in 2025
14 Feb 2025
Equity Research Ecoclime, Q4 2024: Weak quarter, but expected to improve in 2025
Equity Research
Equity Research KlaraBo, Q4 2024: Better management results and large property value gains
14 Feb 2025
Equity Research KlaraBo, Q4 2024: Better management results and large property value gains
Equity Research KlaraBo
Equity Research Nosa Plugs: First impression Q4, 2024
14 Feb 2025
Equity Research Nosa Plugs: First impression Q4, 2024
Equity Research Nosa Plugs
Equity research CDON Q4 2024: First impression
13 Feb 2025
Equity research CDON Q4 2024: First impression
Equity Research CDON
Equity Research GIAB, Q4 2024: Lack of liquidity due to weak sales
13 Feb 2025
Equity Research GIAB, Q4 2024: Lack of liquidity due to weak sales
Equity Research
Carlsquare Equity Research interview with Biosergen
11 Feb 2025
Carlsquare Equity Research interview with Biosergen
Equity Research Biosergen
Equity Research ALM Equity, Q4 2024: Improved outlook for housing development in 2025
10 Feb 2025
Equity Research ALM Equity, Q4 2024: Improved outlook for housing development in 2025
Equity Research ALM Equity
Carlsquare hat die Gesellschafter von imoTRAFFIC beim Verkauf an die AVS Gruppe beraten
06 Feb 2025
Carlsquare hat die Gesellschafter von imoTRAFFIC beim Verkauf an die AVS Gruppe beraten
Deal News